|Articles|October 1, 2007
- Volume 0 0
Seven Deadly Sins AND HOW TO AVOID THEM: R?sum?
Advertisement
- SPELLING ERRORS?Proof, reproof, and have at least 2 reviewers proof your r?sum?.
- DIRTY/UNCLEAR PRINT?Print in traditional fonts with a size of at least 12 points, using a laser printer.
- POOR QUALITY PAPER?Purchase a high-grade, heavy bonded paper.
- WEAK CAREER OBJECTIVE?Write an objective that is ?employer-oriented? and not purely self-serving.
- NO COVER LETTER?Attach a cover letter that introduces you and your interest in the position.
- EXTRANEOUS MARKS, FOLDS, WRINKLES, TEARS?Keep your r?sum?s in a firm, closed folder.
- IMPERSONAL MAILING ADDRESS?Send your r?sum? to the individual who will make the hiring decision?not to thecompany or ?to whom it may concern.?
Articles in this issue
almost 19 years ago
Seven Deadly Sins AND HOW TO AVOID THEM: Interviewsalmost 19 years ago
PRUITT-SCHUTTE COMPETITION STRIVES FOR EXCELLENCEalmost 19 years ago
DOCTOR TOM'S TOP TEN TIPS: PASSING THE PHARMACY BOARDSalmost 19 years ago
PHARMACY GROUPS JOIN TOGETHER TO IMPROVE SERVICEalmost 19 years ago
STUDENT POLITICAL INVOLVEMENT DOES IMPACT PHARMACYalmost 19 years ago
OWNING YOUR OWN PHARMACY: A PLAN AND PARTNERSHIP COME TOGETHERalmost 19 years ago
TECHNOLOGY EXPANDS PHARMACY REACH IN UNDERSERVED RURAL AREASalmost 19 years ago
PARTNERSHIP PROGRAMS?A WIN-WIN FOR COMMUNITY PHARMACISTSalmost 19 years ago
GOOD NEIGHBOR PHARMACY REWARDS EXCELLENCEalmost 19 years ago
WELCOME TO INDEPENDENT PHARMACYAdvertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
Thoracic Radiotherapy Added to Atezolizumab Raises Fatal Toxicity Risk in ES-SCLC
3
Q&A: Pharmacists' Role in CKD Grows as Finerenone Eyes Label Expansion
4
Lilly Prepares for Retatrutide FDA Filing Following Additional Phase 3 Data in Diabetes, CVD
5